GlassScriptPhysician profile
Beverly H Ortiz
NPI 1639110802
$22,840.50
in general payments reported to CMS, 2019-2025
17 companies · $32.16 in 2025
The $32.16 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $27.67 · 2021: $118 · 2022: $128 · 2023: $95.05 · 2024: $757 · 2025: $32.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.67 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $21,654.31 | 2019-2020 | |
| Intuitive Surgical, INC. | $675.33 | 2024 | |
| Glaxosmithkline, LLC. | $100.15 | 2020-2024 | Jemperli, Zejula |
| Myriad Genetic Laboratories, INC. | $80.00 | 2021-2024 | Myrisk, Precisetumor |
| Abbvie INC. | $61.47 | 2019-2024 | |
| Immunogen, INC. | $40.96 | 2023 | Elahere |
| Davol INC. | $34.98 | 2022 | |
| Ethicon US, LLC | $34.34 | 2021-2025 | Stratafix, Vistaseal |
| Axonics, INC. | $23.89 | 2021 | |
| Olympus America INC. | $22.47 | 2019 | |
| Hologic Sales and Service, LLC | $20.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.20 | 2022 | |
| Smith+Nephew, INC. | $15.90 | 2021 | |
| Urovant Sciences INC | $14.91 | 2022 | |
| Pfizer INC. | $14.85 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $14.47 | 2022 | |
| Shield Therapeutics INC | $14.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.